Medical Device

SeaSpine (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the portfolio expansion of the Ventura™NanoMetalene® posterior interbody device. As quoted in the press release: The Ventura interbody devices feature proprietary NanoMetalene surface technology. NanoMetalene describes a sub-micron layer of commercially pure titanium molecularly bonded to a PEEK …

SeaSpine (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the portfolio expansion of the VenturaNanoMetalene® posterior interbody device.
As quoted in the press release:

The Ventura interbody devices feature proprietary NanoMetalene surface technology. NanoMetalene describes a sub-micron layer of commercially pure titanium molecularly bonded to a PEEK implant using a high-energy, low-temperature process referred to as atomic fusion deposition. It is designed to provide implants a bone-friendly titanium surface on endplates and throughout graft apertures, while retaining the benefits associated with traditional PEEK implants, such as biocompatibility, a modulus of elasticity similar to bone, and excellent radiographic visibility for post-operative imaging.

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20101.38-389.63
TSXV691.17-21.32
DOW31490.07-1164.52
S&P 5003923.68-165.17
NASD11418.15-566.37
ASX7112.50+19.50

COMMODITIES

Commodities
Gold1816.41+1.83
Silver21.34-0.28
Copper4.15-0.03
Palladium1998.00-47.00
Platinum931.00-20.00
Oil108.06-1.53
Heating Oil3.56-0.01
Natural Gas8.14-0.23

DOWNLOAD FREE REPORTS

×